STUDY OF RISK FACTORS FOR THE DEVELOPMENT OF INFANTILE HEMANGIOMA IN CHILDREN
DOI:
https://doi.org/10.54890/.v4i4.1062Abstract
Infantile hematoma is the most common vascular tumor in childhood, which in most cases resolves on its own. However, in some cases, with aggressive growth, the disease can occur with complications. The purpose of this work was an integrated study of risk factors for the development of infantile hemangioma. The study involved 138 patients, including 69 patients diagnosed with infantile hemangioma, aged 6-78 months. The control group was formed from 69 healthy children comparable in number, age and gender with the children of the main group. Anthropometric data were assessed and socio-demographic characteristics, medical history, and family history were analyzed in patients with IH using a developed patient monitoring form. Based on these data, the ranking significance of risk factors for the occurrence of infantile hemangioma in children was calculated. This study showed that antenatal factors and heredity have the highest probability of occurrence of the disease. Peri- and postnatal factors were of low significance. Further scientific research should be aimed at studying the relationship between risk factors and their influence on the further course of the disease.
Keywords:
infantile hemangioma, children, risk factors.References
1. Василевская Е.А., Варданян К.Л., Дзыбова Э.М. Современные методы лечения инфантильных гемангиом. Клиническая дерматология и венерология. 2015;6:15-19. [Vasilevskaya E.A., Vardanyan K.L., Dzybova E.M. Modern treatments of infantile hemangiomas. Clinical dermatology and venereology. 2015;6:15-19. (in Russ.)]. https://doi.org/10.17116/klinderma201514615-19
2. Kitami M. Diffusion-weighted imaging as a routine MRI protocol for the evalution of infantile hemangioma. Clin Imaging. 2017;46:121. https://doi.org/10.2016/j.clinimag.2017.07.015
3. Омурзаков Б.А. Применение в-адреноблокаторов при лечении гемангиомы у детей / Б.А. Омурзаков. Вестник КРСУ. 2015;15(7):133-135. [Omurzakov B.A. Beta-blockers in the treatment of hemangiomas in children. Herald of KRSU. 2015;15(7):133-135.]
4. Хачатрян Л.А., Клецкая И.С. Просто о сложном: инфантильная гемангиома (обзор литературы). Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2021;20(1):192‒206. [Khachatryan L. A., Kletskaya I. S. Just about the complex: infantile hemangioma (literature review). Pediatric Hematology/Oncology and
Immunopathology 2021;20(1):192‒206. (in Russian)]. https://doi.org/10.24287/1726-1708-2021-20-1-192-206